Reviews Multiple Electrolytes and Dextrose Injection


No reviews yet.

Plasma-Lyte 148 and 5% Dextrose Injection Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(Multiple Electrolytes and Dextrose Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions ( > 600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 3/6/2009




Plasma-Lyte 148 and 5% Dextrose Injection Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(Multiple Electrolytes and Dextrose Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions ( > 600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 3/6/2009




Plasma-Lyte 148 and 5% Dextrose Injection Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(Multiple Electrolytes and Dextrose Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions ( > 600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 3/6/2009




Plasma-Lyte 148 and 5% Dextrose Injection Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(Multiple Electrolytes and Dextrose Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions ( > 600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 3/6/2009




Plasma-Lyte 148 and 5% Dextrose Injection Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(Multiple Electrolytes and Dextrose Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions ( > 600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 3/6/2009





Other reviews about Multiple Electrolytes and Dextrose Injection on wordpress

kuis endokrin
  by atTock
Questions 1-3 An 8-year-old, previously healthy girl is brought in for evaluation of altered mental status. She is lethargic but is protecting her airway. She has a blood pressure […]


Anesthesia Memos
  by mwhauser
AAA: ENDOVASCULAR The endovascular AAA repair is typically performed under high lumbar or low thoracic epidural anesthesia with MAC. LIDOCAINE is often a good choice as these patients […]


MEDICAL SURGICAL NURSING - Q&A
  by philippinenurse
MEDICAL SURGICAL NURSING 1. Following surgery, Mario complains of mild incisional pain while performing deep- breathing and coughing exercises. The nurse’s best response would be: A.“Pain will become less each […]


lish12 Vitamin Deficiencies
  by kraeplinpsychiatry
Page 570 Chapter 12: Vitamin DeficienciesSevere chronic malnutrition is accompanied by wellknown psychological changes-apathy, emotional lability, retardation, impairment of memory and sometimes acute psychotic illness. Such manifestations have […]


12 Vitamin Deficiencies
  by kraeplinpsychiatry
Chapter 12: Vitamin DeficienciesSevere chronic malnutrition is accompanied by wellknown psychological changes-apathy, emotional lability, retardation, impairment of memory and sometimes acute psychotic illness. Such manifestations have been described […]


Do you understand your rights?
  by azjxmtywexafh
They got there just after dark, Stu moving the Plymouth carefully in low gear through the dark streets, which were dotted with abandoned cars. And with that, the […]


said Nicholas, forgetting at the instant
  by vremyjtlvxku
He was only a youngstertwentytwo; he had to be to do it. At the same moment there was the unmistakable ripping sound of a really good fart. She […]


While he was still under
  by jteevvywqu
There is the blonde who gives you the upfromunder look and smells lovely and shimmers and hangs on your arm and is always very very tired when you […]


It was a warm day, almost the end of M
  by qjrxntzsfuby
Now she came back also gazing with frank wonder. But this theory supposes that the people who tend to recover from longterm coma are people who have sustained […]


ANNYS [The atmosphere has grown
  by zfktvdflpszrzbr
I said whatever seemed to be appropriate, and next morning my deliverance came. They saw this scary movie, said they had to wash their shorts after. An […]



Other reviews about Multiple Electrolytes and Dextrose Injection on web:

Learn about the prescription medication Plasma-Lyte M and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection), drug uses, dosage, side effects, drug interactions ... Plasma-Lyte M and 5% Dextrose Injection (Multiple Electrolytes and ...


Electrolyte E is extracellular replacement solution and has same composition as plasma. It provides physiological concentration of sodium and chloride and also potassium, calcium ... Multiple Electrolytes and Dextrose Injection


Electrolyte M is an adult's daily maintenance solution. It provides daily needs of water and electrolytes to the body without exceeding body's tolerance for them. Multiple Electrolytes and Dextrose Injection Type 3USP


Learn about the prescription medication Plasma-Lyte 56 and Dextrose (Multiple Electrolytes and Dextrose Injection in Viaflex Plastic Container), drug uses, dosage, side effects ... Plasma-Lyte 56 and Dextrose (Multiple Electrolytes and Dextrose ...


»Multiple Electrolytes and Dextrose Injection Type 3is a sterile solution of Dextrose and suitable salts in Water for Injection to provide sodium,potassium,and chloride ions.In ... Multiple Electrolytes and Dextrose Injection Type 3, chemical ...


Ionosol T and 5% Dextrose Injection (Multiple Electrolytes and 5% Dextrose Injection Type 3, USP) is a sterile, nonpyrogenic fluid electrolyte replenisher and ... Ionosol® T and 5% Dextrose Injection(Multiple ...


5% Dextrose and Electrolyte No. 48 Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) 2B2103Q Baxter US Product Catalog - 5% Dextrose and Electrolyte No. 48 ...


Normosol-M And Dextrose Injection, Solution - Normosol-M and 5% Dextrose Injection (Multiple Electrolytes and 5% Dextrose Injection Type 1, USP) is indicated for parenteral ... Normosol-M And Dextrose Injection, Solution drug information ...


5% Dextrose and Electrolyte No. 75 Injection (Multiple Electrolytes and Dextrose Injection, Type 3, USP) is indicated as a source of water, electrolytes and calories or as an ... Dextrose Electrolyte No. 75 Official FDA information, side effects ...


Multiple Electrolytes and Dextrose Injection Type 4 active ingredients names and forms, pharmaceutical companies, indications and usages, online pharmacy health products information Multiple Electrolytes and Dextrose Injection Type 4 (Calcium ...





Featured Reviews

Reviews Multitrace 5 Concentrate

Multitrace 5 Concentrate Drug Description MULTITRACE® - 5 CONCENTRATE (trace elements) Injection 5 FOR IV USE AFTER DILUTION DRUG DESCRIPTION MULTITRACE® - 5 CONCENTRATE (TRACE ELEMENTS INJECTION 5, USP) is a sterile nonpyrogenic...
Read More  |  Review This
Reviews Gonadorelin

Factrel Drug Description DRUG DESCRIPTION What are the possible side effects of gonadorelin (Factrel)? If you experience a rare allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face;...
Read More  |  Review This
Reviews Ramelteon

Rozerem Drug Description ROZEREM (ramelteon) Tablets DRUG DESCRIPTION What are the possible side effects of ramelteon (Rozerem)? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty...
Read More  |  Review This
Reviews Pneumococcal Vaccine Polyvalent

Pneumovax Drug Description PNEUMOVAX® 23 (pneumococcal) Vaccine Polyvalent DRUG DESCRIPTION What are the possible side effects of pneumococcal polysaccharide vaccine (Pneumovax 23, Pnu-Imune 23)? Getting pneumococcal disease...
Read More  |  Review This
Reviews Nefazodone

Serzone Drug Description SERZONE® (nefazodone hydrochloride) Tablets WARNING Cases of life-threatening hepatic failure have been reported in patients treated with SERZONE. The reported rate in the United States is about 1 case of...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....